Medtronic received information that during use of a nt oxygenator, it was reported that approximately 45 minutes into the pump run, the perfusionist noticed a small very slow blood leak from the temperature probe site near the outlet of the oxygenator.The device was used to complete the procedure.There was no patient impact associated with this event.Medtronic received additional information that the patient was normothermic at the time with no other issues or concerns with the case.It was anticipated that there was less than a 10cc blood loss from the port through out the operation.The perfusionist did not feel that the oxygenator warranted an emergent change out and used the affected oxygenator throughout the entire case.After the case the perfusionist performed a visual inspection and did not observe any gross cracks or breaks.
|
Product analysis: visual inspection showed no evidence of any cracks in the temperature port (tma).Pressure integrity testing was performed at 3 l/pm with 23 psi, (1189 mmhg) of back pressure for 10 minutes.During the pressure integrity testing there was a leak observed at the tma port.The reason for return was confirmed.If information is provided in the future, a supplemental report will be issued.
|
Medtronic received additional information stating that a transfusion was not required because of the leak.The perfusionist stated that they could not appreciate where the leak occurred, at the oxygenator or direct from the connector.Conclusion: the reported complaint was confirmed.The device was returned for analysis and confirmed a tma leak.Trends for issues with this device are monitored.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|